Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pharmacoeconomics
; 35(1): 97-109, 2017 01.
Article
en En
| MEDLINE
| ID: mdl-27506954
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Neoplasias Peritoneales
/
Ftalazinas
/
Piperazinas
/
Neoplasias de las Trompas Uterinas
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Health_economic_evaluation
/
Health_technology_assessment
Límite:
Female
/
Humans
Idioma:
En
Año:
2017
Tipo del documento:
Article